MedTrace Logo

MyPEEPS LITE Trial

NCT06741631 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3200

Last updated 2026-02-27

No results posted yet for this study

Summary

This study will use community-informed advertisements and messages through electronic methods to recruit and retain a large (N=3,200), diverse national sample of high-risk young men who have sex with men (YMSM) and non-binary individuals that are assigned male sex at birth, 16-29 years of age to determine the efficacy of the MyPEEPS Mobile intervention on reduced incident HIV infections in comparison to a standard of care condition and to examine the degree to which reduced incident HIV infections occurs in the context of potential multilevel moderators and conceptual mediators. This is key to advancing HIV prevention among HIV-negative US persons at extremely high-risk for HIV seroconversion.

Conditions

Interventions

BEHAVIORAL

MyPEEPS Mobile

An evidence-based, digitally delivered mHealth sexual risk reduction intervention on HIV incidence.

Sponsors & Collaborators

  • Ann & Robert H Lurie Children's Hospital of Chicago

    collaborator OTHER

  • Northwestern University

    collaborator OTHER

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • Rebecca Schnall, PhD, MPH · Columbia University

  • Robert Garofalo, MD, MPH · Ann & Robert H Lurie Children's Hospital of Chicago

  • Dustin Duncan, ScD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
29 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-10
Primary Completion
2027-12-01
Completion
2028-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06741631 on ClinicalTrials.gov